Results 161 to 170 of about 41,502 (266)

Blue‒Green Neutrophilic Inclusions in a Cat With Severe Hepatocellular Injury

open access: yesVeterinary Medicine and Science, Volume 12, Issue 5, September 2026.
A 5‐year‐old cat presented with fever, lethargy and inappetence and was found to have blue‒green neutrophilic inclusions on blood smear evaluation. Concurrent clinicopathologic abnormalities were consistent with severe acute hepatopathy, including markedly increased alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities ...
Zynia R. Alvarez   +4 more
wiley   +1 more source

Incidence and predictors of neonatal hyperbilirubinemia requiring phototherapy: A prospective cohort study at a tertiary hospital in Uganda. [PDF]

open access: yesPLoS One
Yusuf HM   +15 more
europepmc   +1 more source

Evidence-based nursing practices in newborn hyperbilirubinemia

open access: yes
Hyperbilirubinemia, defined as an elevated level of total serum bilirubin in the blood, is observed in approximately 60% of term infants and around 80% of preterm infants.
Yildirim, Maksude
core  

GLUT1 Deficiency Syndrome with Coexistent Movement Disorder and Anemia

open access: yes
Movement Disorders Clinical Practice, Volume 13, Issue 9, Page 2281-2283, September 2026.
Sangeetha Yoganathan   +12 more
wiley   +1 more source

Bile‐Derived Exosomal miR‐196a/‐196b as Diagnostic Biomarkers Associated With Tumor Progression in Biliary Tract Cancer

open access: yesCancer Science, Volume 117, Issue 9, Page 2521-2534, September 2026.
Bile‐derived exosomal miR‐196a and miR‐196b are identified as novel biomarkers for biliary tract cancer. Serum miR‐196a levels are significantly elevated in advanced disease with metastasis, while both miRNAs contribute to tumor progression by promoting cancer cell proliferation and invasion.
Naotaka Kugiyama   +20 more
wiley   +1 more source

USP34 Haploinsufficiency as a Cause of Neurodevelopmental Phenotypes

open access: yesClinical Genetics, Volume 110, Issue 3, Page 315-324, September 2026.
Heterozygous loss‐of‐function variants in USP34 cause a novel neurodevelopmental disorder characterized by global developmental delay, speech impairment, autism, hypotonia, craniofacial dysmorphism, and distal limb anomalies. Disrupted Wnt/β‐catenin signaling via reduced Axin stabilization refines gene‐specific contributions within 2p15p16.1 ...
Helena Wigoda   +10 more
wiley   +1 more source

Targeting m6A Modifications Regulating Ferroptosis Offers Novel Therapy in Diseases

open access: yesCell Proliferation, Volume 59, Issue 9, September 2026.
m6A RNA modification regulates ferroptosis by balancing iron metabolism, lipid peroxidation, and antioxidant defenses. Dysregulated m6A signaling disrupts pro‐ and anti‐ferroptotic factors, leading to excess ROS, Fe3+ accumulation, and lipid peroxidation–driven cell death. Targeting m6A‐mediated ferroptotic regulation represents a promising therapeutic
Lida Du   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy